LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 513 | 10676 | 10483 | 1.0184 | 1.0084 |
MCF 10A | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 513 | 5967 | 10537 | 0.5662 | 0.7554 |
MCF 10A | Withaferin A | 0.37 | uM | LJP6 | 2 | G16 | 72 | hr | 513 | 6690 | 10386 | 0.6441 | 0.8072 |
MCF 10A | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 513 | 6237 | 10494 | 0.5943 | 0.7747 |
MCF 10A | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 513 | 6851 | 10254 | 0.6681 | 0.8217 |
MCF 10A | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 513 | 7276 | 10349 | 0.7030 | 0.8438 |
MCF 10A | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 513 | 7517 | 10483 | 0.7170 | 0.8528 |
MCF 10A | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 513 | 375 | 10537 | 0.0356 | -0.0695 |
MCF 10A | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 513 | 557 | 10386 | 0.0536 | 0.0190 |
MCF 10A | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 513 | 574 | 10494 | 0.0547 | 0.0260 |
MCF 10A | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 513 | 433 | 10254 | 0.0422 | -0.0386 |
MCF 10A | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 513 | 445 | 10349 | 0.0430 | -0.0324 |
MCF 10A | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 513 | 462 | 10483 | 0.0441 | -0.0239 |
MCF 10A | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 513 | 290 | 10537 | 0.0275 | -0.1228 |
MCF 10A | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 513 | 369 | 10386 | 0.0355 | -0.0733 |
MCF 10A | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 513 | 377 | 10494 | 0.0359 | -0.0685 |
MCF 10A | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 513 | 355 | 10254 | 0.0346 | -0.0818 |
MCF 10A | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 513 | 405 | 10349 | 0.0391 | -0.0532 |
MCF 10A | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 513 | 364 | 10483 | 0.0347 | -0.0760 |
MCF 10A | Withaferin A | 10 | uM | LJP6 | 1 | G13 | 72 | hr | 513 | 236 | 10537 | 0.0224 | -0.1633 |
MCF 10A | Withaferin A | 10 | uM | LJP6 | 2 | G13 | 72 | hr | 513 | 301 | 10386 | 0.0290 | -0.1158 |
MCF 10A | Withaferin A | 10 | uM | LJP6 | 3 | G13 | 72 | hr | 513 | 438 | 10494 | 0.0417 | -0.0358 |
MCF 10A | Withaferin A | 10 | uM | LJP5 | 1 | G13 | 72 | hr | 513 | 248 | 10254 | 0.0242 | -0.1550 |
MCF 10A | Withaferin A | 10 | uM | LJP5 | 2 | G13 | 72 | hr | 513 | 359 | 10349 | 0.0347 | -0.0792 |
MCF 10A | Withaferin A | 10 | uM | LJP5 | 3 | G13 | 72 | hr | 513 | 358 | 10483 | 0.0341 | -0.0795 |